Technical Analysis for SBFM - Sunshine Biopharma Inc.

Grade Last Price % Change Price Change
F 2.84 0.71% 0.02
SBFM closed up 0.71 percent on Friday, November 1, 2024, on 31 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Nov 11
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Bollinger Band Squeeze Range Contraction 0.71%
Lower Bollinger Band Walk Weakness 0.71%
BB Squeeze + Lower Band Touch Range Contraction 0.71%
Gapped Up Strength 0.71%
Below Lower BB Weakness 0.71%

   Recent Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Sunshine Biopharma Inc. Description

Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; and SBFM-PL4, an anti-coronavirus treatment compound. It also provides generic prescription drugs for the treatment of breast cancer, prostate cancer, and benign prostatic hyperplasia; and Essential 9, a dietary supplement tablet. Sunshine Biopharma, Inc. has a license agreement with the University of Georgia to advance the development of two anti-coronavirus compounds in parallel with its anti-coronavirus lead compound, SBFM-PL4. Sunshine Biopharma, Inc. was founded in 2006 and is headquartered in Pointe-Claire, Canada.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Cancer Pharmaceutical Breast Cancer Lymphoma Prostate Cancer Dietary Supplement Treatment Of Breast Cancer Pancreatic Cancer Small Cell Lung Cancer Leukemia Benign Prostatic Hyperplasia Hyperplasia Histopathology Prostate

Is SBFM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 640.0
52 Week Low 2.42
Average Volume 170,329
200-Day Moving Average 75.77
50-Day Moving Average 2.97
20-Day Moving Average 2.98
10-Day Moving Average 2.96
Average True Range 0.17
RSI (14) 41.86
ADX 16.4
+DI 18.27
-DI 14.60
Chandelier Exit (Long, 3 ATRs) 2.68
Chandelier Exit (Short, 3 ATRs) 3.28
Upper Bollinger Bands 3.13
Lower Bollinger Band 2.82
Percent B (%b) 0.06
BandWidth 10.50
MACD Line -0.07
MACD Signal Line -0.06
MACD Histogram -0.0105
Fundamentals Value
Market Cap 79.59 Million
Num Shares 28 Million
EPS -1.63
Price-to-Earnings (P/E) Ratio -1.74
Price-to-Sales 0.26
Price-to-Book 0.29
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.07
Resistance 3 (R3) 3.08 3.01 3.03
Resistance 2 (R2) 3.01 2.96 3.01 3.01
Resistance 1 (R1) 2.93 2.92 2.97 2.92 3.00
Pivot Point 2.86 2.86 2.89 2.86 2.86
Support 1 (S1) 2.78 2.81 2.82 2.77 2.68
Support 2 (S2) 2.71 2.77 2.71 2.67
Support 3 (S3) 2.63 2.71 2.65
Support 4 (S4) 2.62